Nordic Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NORDIC PHARMA, and what generic and branded alternatives to NORDIC PHARMA drugs are available?
NORDIC PHARMA has one approved drug.
Summary for Nordic Pharma
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Nordic Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nordic Pharma | NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN | gramicidin; neomycin sulfate; polymyxin b sulfate | SOLUTION/DROPS;OPHTHALMIC | 065187-001 | Oct 28, 2005 | AT | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
